Anti-Cancer Drugs

Title Publication Date Language Citations
Chemosensitization and drug accumulation effects of VX-710, verapamil, cyclosporin A, MS-209 and GF120918 in multidrug resistant HL60/ADR cells expressing the multidrug resistance-associated protein MRP1997/02/01English87
Combretastatin A4 phosphate2004/03/01English86
Effects of intra-abdominal pressure on pharmacokinetics and tissue distribution of doxorubicin after intraperitoneal administration1996/07/01English86
Cellular and biochemical characterization of VX-710 as a chemosensitizer1997/02/01English86
Cytotoxicity of digitoxin and related cardiac glycosides in human tumor cells2001/06/01English86
Lack of usefulness of epidermal growth factor receptor expression determination for cetuximab therapy in patients with colorectal cancer2006/08/01English85
Correlations between the activities of 19 anti-tumor agents and the intracellular glutathione concentrations in a panel of 14 human cancer cell lines: comparisons with the National Cancer Institute data2006/01/01English85
Cisplatin resistance and oncogenes - a review2000/04/01English85
Phase II study of gemcitabine as first-line chemotherapy in patients with advanced or metastatic breast cancer1999/02/01English84
Use of granisetron in patients refractory to previous treatment with antiemetics1998/06/01English84
Understanding the molecular-based mechanism of action of the tyrosine kinase inhibitor: sunitinib2010/01/01English83
Caffeic acid phenethyl ester induces growth arrest and apoptosis of colon cancer cells via the β-catenin/T-cell factor signaling2006/08/01English82
Use of an ex vivo ATP luminescence assay to direct chemotherapy for recurrent ovarian cancer1998/01/01English82
Double minute chromosomes and homogeneously staining regions in tumors taken directly from patients versus in human tumor cell lines1991/02/01English82
Modulating effect of resveratrol and quercetin on oral cancer cell growth and proliferation1999/02/01English82
Usnic acid: a non-genotoxic compound with anti-cancer properties2005/09/01English81
Doxorubicin-peptide conjugates overcome multidrug resistance2001/02/01English81
From bench to bedside for gene-directed enzyme prodrug therapy of cancer2005/04/01English81
Sodium valproate inhibits in vivo growth of human neuroblastoma cells1997/11/01English80
Efficacy and toxicity of bendamustine in patients with relapsed low-grade non-Hodgkinʼs lymphomas2001/10/01English80
Anti-tumor efficacy and biodistribution of intravenous polymeric micellar paclitaxel1997/08/01English79
Prolonged clinical benefit with metronomic chemotherapy in patients with metastatic breast cancer2006/09/01English79
Cisplatin-associated neurotoxicity1995/06/01English79
Docetaxel (Taxotere®), a review of preclinical and clinical experience. Part II1995/06/01English79
Taxol1992/08/01English79
Effects of Taxotere and taxol on in vitro colony formation of freshly explanted human tumor cells1992/04/01English78
Mitotic index and cell proliferation kinetics for identification of antineoplastic activity1993/12/01English78
The modulated oral fluoropyrimidine prodrug S-1, and its use in gastrointestinal cancer and other solid tumors2004/02/01English78
Modulation of camptothecin analogs in the treatment of cancer: a review2001/02/01English77
Use of corticosteroids in neuro-oncology1995/02/01English77